PL333464A1 - Application of phosphonic esters in treatment and prophylactics of cerebral functional disorders and depressions - Google Patents

Application of phosphonic esters in treatment and prophylactics of cerebral functional disorders and depressions

Info

Publication number: PL333464A1
Authority: PL; Poland
Prior art keywords: prophylactics; depressions; treatment; application; functional disorders
Prior art date: 1996-04-25

Application number

PL97333464A

Other languages

English (en)

Inventor

Fritz Maurer

Bernard Schmidt

Stephan Lensky

Der Staay Franz-Josef Van

Richard Joseph Fanelli

David Ross Britelli

Original Assignee

Troponwerke Gmbh & Co Kg

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-04-25

Filing date

1997-04-17

Publication date

1999-12-20

1997-04-17 Application filed by Troponwerke Gmbh & Co Kg, Bayer Ag filed Critical Troponwerke Gmbh & Co Kg

1999-12-20 Publication of PL333464A1 publication Critical patent/PL333464A1/xx

Links

230000002490 cerebral effect Effects 0.000 title 1
150000002148 esters Chemical class 0.000 title 1
230000000069 prophylactic effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL97333464A 1996-04-25 1997-04-17 Application of phosphonic esters in treatment and prophylactics of cerebral functional disorders and depressions PL333464A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19616471A DE19616471A1 (de)	1996-04-25	1996-04-25	Phosponsäureester zur Behandlung von Hirnleistungsstörungen und Depressionen

Publications (1)

Publication Number	Publication Date
PL333464A1 true PL333464A1 (en)	1999-12-20

Family

ID=7792381

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL97333464A PL333464A1 (en)	1996-04-25	1997-04-17	Application of phosphonic esters in treatment and prophylactics of cerebral functional disorders and depressions

Country Status (19)

Country	Link
EP (1)	EP0896540A1 (id)
JP (1)	JP2000510455A (id)
KR (1)	KR20000010611A (id)
AR (1)	AR006870A1 (id)
AU (1)	AU2462397A (id)
BG (1)	BG102864A (id)
BR (1)	BR9709300A (id)
CA (1)	CA2252567A1 (id)
CZ (1)	CZ343498A3 (id)
DE (1)	DE19616471A1 (id)
HU (1)	HUP9903366A3 (id)
ID (1)	ID16678A (id)
IL (1)	IL126698A0 (id)
NO (1)	NO984964L (id)
PL (1)	PL333464A1 (id)
SK (1)	SK146398A3 (id)
TR (1)	TR199802137T2 (id)
WO (1)	WO1997039756A1 (id)
ZA (1)	ZA973538B (id)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1078370B (de) *	1958-09-16	1960-03-24	Norddeutsche Affinerie	Schaedlingsbekaempfungsmittel
US3069312A (en) *	1960-09-28	1962-12-18	California Research Corp	N-substituted dimethyl 1-carbamoyloxy-2, 2, 2-trichloroethyl phosphonates as insecticidal compositions
BE632366A (id) *	1962-05-16	1900-01-01
DE1193044B (de) *	1963-08-05	1965-05-20	Bayer Ag	Verfahren zur Herstellung phosphorylierter Urethane
DE2512375A1 (de) *	1975-03-21	1976-09-30	Bayer Ag	1-hydroxy-2,2,2-trichloraethan- thionophosphonsaeuredialkylester, verfahren zu ihrer herstellung sowie ihre verwendung als insektizide
US4950658A (en) *	1988-12-06	1990-08-21	Board Of Trustees Of Southern Illinois Univ.	Method of medical treatment of Alzheimer's disease

1996
- 1996-04-25 DE DE19616471A patent/DE19616471A1/de not_active Withdrawn
1997
- 1997-04-17 CZ CZ983434A patent/CZ343498A3/cs unknown
- 1997-04-17 IL IL12669897A patent/IL126698A0/xx unknown
- 1997-04-17 PL PL97333464A patent/PL333464A1/xx unknown
- 1997-04-17 SK SK1463-98A patent/SK146398A3/sk unknown
- 1997-04-17 TR TR1998/02137T patent/TR199802137T2/xx unknown
- 1997-04-17 HU HU9903366A patent/HUP9903366A3/hu unknown
- 1997-04-17 JP JP09538197A patent/JP2000510455A/ja active Pending
- 1997-04-17 WO PCT/US1997/006469 patent/WO1997039756A1/en not_active Ceased
- 1997-04-17 EP EP97920431A patent/EP0896540A1/en not_active Withdrawn
- 1997-04-17 KR KR1019980708502A patent/KR20000010611A/ko not_active Withdrawn
- 1997-04-17 AU AU24623/97A patent/AU2462397A/en not_active Abandoned
- 1997-04-17 CA CA002252567A patent/CA2252567A1/en not_active Abandoned
- 1997-04-17 BR BR9709300A patent/BR9709300A/pt not_active Application Discontinuation
- 1997-04-24 ZA ZA9703538A patent/ZA973538B/xx unknown
- 1997-04-24 ID IDP971362A patent/ID16678A/id unknown
- 1997-04-25 AR ARP970101724A patent/AR006870A1/es unknown
1998
- 1998-10-22 BG BG102864A patent/BG102864A/xx unknown
- 1998-10-23 NO NO984964A patent/NO984964L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO1997039756A1 (en)	1997-10-30
IL126698A0 (en)	1999-08-17
TR199802137T2 (xx)	1999-02-22
ID16678A (id)	1997-10-30
NO984964D0 (no)	1998-10-23
NO984964L (no)	1998-12-22
CA2252567A1 (en)	1997-10-30
BR9709300A (pt)	1999-08-10
AR006870A1 (es)	1999-09-29
CZ343498A3 (cs)	1999-02-17
EP0896540A1 (en)	1999-02-17
ZA973538B (en)	1997-11-18
JP2000510455A (ja)	2000-08-15
AU2462397A (en)	1997-11-12
HUP9903366A2 (en)	2000-07-28
KR20000010611A (ko)	2000-02-25
HUP9903366A3 (en)	2000-08-28
DE19616471A1 (de)	1997-10-30
SK146398A3 (en)	1999-06-11
BG102864A (en)	1999-09-30

Similar Documents

Publication	Publication Date	Title
HUP9800033A3 (en)	2001-04-28	Compositions for the treatment of dermatological disorders and methods for their use
EP0924983A4 (en)	1999-08-25	S (-) - TOLTERODINE FOR THE TREATMENT OF URINARY AND GASTROINTESTINAL DISORDERS
EP0904266A4 (en)	2001-09-19	NITROSIZED AND NITROSYLATED COMPOUNDS AND PREPARATIONS AND THE USE THEREOF FOR TREATING RESPIRATORY DISEASES
IL117229A0 (en)	1996-06-18	Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders
IL121268A0 (en)	1998-01-04	Branched chain fatty acids their derivatives and use in the treatment of central nervous system disorders
PL330713A1 (en)	1999-05-24	Spry-dried compositions of polymers and treatment methods
AU4775797A (en)	1998-04-17	Process for the determination of app secretase modulators and the use thereof as agents in the treatment of alzheimer's disease
AU2466695A (en)	1995-11-29	The use of famotidine and related compounds in the treatment of movement disorders
ZA951088B (en)	1996-01-23	Use of substituted arylcyclobutylalkylamine compounds in the treatment of seizures neurological disorders and neurological damage
AU3497097A (en)	1998-01-07	Improved method for treatment and diagnosis of il-5 mediated disorders
GB2314273B (en)	2000-09-27	The use of TCET in the prophylaxis and treatment of allergies
AU3965497A (en)	1998-02-20	Methods of treatment of eye trauma and disorders
PL332313A1 (en)	1999-08-30	Application of benzopyranoles in treatment of neurological disorders
GB9321341D0 (en)	1993-12-08	Therapeutic compositions for use in the treatment of skin lesions and method of making same
PL320922A1 (en)	1997-11-10	Application of mhc-ii bonding and/or somulating molecules in prevention and/or treatment of diseases involving inflammatory processes
PL333464A1 (en)	1999-12-20	Application of phosphonic esters in treatment and prophylactics of cerebral functional disorders and depressions
AU7602894A (en)	1995-03-21	Use of 2-deoxycoformycin (pentostatin) for treating cerebral and cardiovascular disorders
PL330797A1 (en)	1999-06-07	Derivatives of piperidinacetic acid and their application in treating thrombotic disorders
HUP9902802A3 (en)	2002-01-28	Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
EP0893123A4 (en)	2001-05-02	MEANS OF PREVENTIVE AND CURATIVE TREATMENT OF CONDITIONS RELATED TO DIFFERENT FORMS OF AGING OF THE ORGANISM
AU7622798A (en)	1998-06-29	Application of thalidomide to the treatment of Parkinson's disease and Parkisonian syndromes
HUP9701606A3 (en)	1999-07-28	Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psychointellectual disorders
AUPO372596A0 (en)	1996-12-12	Composition and method for the prevention and treatment of skin disorders
SI0833839T1 (en)	2003-10-31	Peptidyl heterocycles useful in the treatment of thrombin related disorders
AU4063797A (en)	1998-03-06	Methods to treat cerebral ischemic injury and other neuronal diseases